Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Increasing Road Accidents And Surgical Procedures
3.2.2. Escalating Palliative Care For Patients Suffering Intensely
3.2.3. Usage Of Abuse Deterrent Formulations To Restrict The Opioid Abuse
3.2.4. Growing Occurrence Of Chronic Pain
3.3. Key Restraints
3.3.1. Misuse Of Opioids
3.3.2. Stringent Regulatory Framework
3.3.3. Opioid Crisis Across The Globe
3.3.4. Increasing Number Of Lawsuits Cases Against Opioids Manufacturers
3.3.5. Rising Occurrence Of Deaths Related To Opioid Overdose

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Regulatory Framework
4.6. Pipeline Analysis
4.7. Industry Events In Opioid Drugs Market
4.8. Technological Advancement

5. Market By Product
5.1. Buprenorphine
5.2. Fentanyl
5.3. Hydrocodone
5.4. Morphine
5.5. Oxycodone
5.6. Tramadol
5.7. Other Products

6. Market By Application
6.1. Pain Relief
6.1.1. Cancer Pain
6.1.2. Postoperative Pain Management
6.1.3. Low Back Pain
6.1.4. Orthopedic
6.1.5. Fibromyalgia
6.1.6. Neuropathic
6.2. Anesthesia
6.3. Cough Suppression
6.4. Diarrhea Suppression
6.5. Deaddiction

7. Geographical Analysis
7.1. North America
7.1.1. United States
7.1.2. Canada
7.2. Europe
7.2.1. United Kingdom
7.2.2. Germany
7.2.3. France
7.2.4. Italy
7.2.5. Russia
7.2.6. Belgium
7.2.7. Poland
7.2.8. Rest Of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. South Korea
7.3.5. Indonesia
7.3.6. Thailand
7.3.7. Vietnam
7.3.8. Australia & New Zealand
7.3.9. Rest Of Asia Pacific
7.4. Rest Of World
7.4.1. Latin America
7.4.2. Middle East And Africa

8. Company Profiles
8.1. Acura Pharmaceuticals Inc
8.2. Allergan Plc
8.3. Biodelivery Sciences International Inc
8.4. Cipher Pharmaceuticals Inc
8.5. Collegium Pharmaceutical Inc
8.6. Daiichi Sankyo Inc
8.7. Egalet Corp
8.8. Hikma Pharmaceuticals Plc
8.9. Indivior Inc
8.10. Janssen Pharmaceuticals Inc
8.11. Johnson & Johnson
8.12. Lannett Co. Inc
8.13. Lupin Ltd
8.14. Mylan Nv
8.15. Pfizer Inc
8.16. Purdue Pharma Lp
8.17. Sanofi-Aventis S.A
8.18. Sun Pharmaceutical Industries Limited (Sun Pharma)
8.19. Teva Pharmaceutical Industries Ltd



List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Global Opioids Drugs Market, Growth Potential, By Product, In 2019
Figure 6: Global Opioids Drugs Market, By Buprenorphine, 2019-2028 (In $ Million)
Figure 7: Global Opioids Drugs Market, By Fentanyl, 2019-2028 (In $ Million)
Figure 8: Global Opioids Drugs Market, By Hydrocodone, 2019-2028 (In $ Million)
Figure 9: Global Opioids Drugs Market, By Morphine, 2019-2028 (In $ Million)
Figure 10: Global Opioids Drugs Market, By Oxycodone, 2019-2028 (In $ Million)
Figure 11: Global Opioids Drugs Market, By Tramadol, 2019-2028 (In $ Million)
Figure 12: Global Opioids Drugs Market, By Other Products, 2019-2028 (In $ Million)
Figure 13: Global Opioids Drugs Market, Growth Potential, By Application, In 2019
Figure 14: Global Opioids Drugs Market, By Pain Relief, 2019-2028 (In $ Million)
Figure 15: Global Opioids Drugs Market, By Cancer Pain, 2019-2028 (In $ Million)
Figure 16: Global Opioids Drugs Market, By Postoperative Pain Management, 2019-2028 (In $ Million)
Figure 17: Global Opioids Drugs Market, By Low Back Pain, 2019-2028 (In $ Million)
Figure 18: Global Opioids Drugs Market, By Orthopedic, 2019-2028 (In $ Million)
Figure 19: Global Opioids Drugs Market, By Fibromyalgia, 2019-2028 (In $ Million)
Figure 20: Global Opioids Drugs Market, By Neuropathic, 2019-2028 (In $ Million)
Figure 21: Global Opioids Drugs Market, By Anesthesia, 2019-2028 (In $ Million)
Figure 22: Global Opioids Drugs Market, By Cough Suppression, 2019-2028 (In $ Million)
Figure 23: Global Opioids Drugs Market, By Diarrhea Suppression, 2019-2028 (In $ Million)
Figure 24: Global Opioids Drugs Market, By Deaddiction, 2019-2028 (In $ Million)
Figure 25: North America Opioids Drugs Market, Regional Outlook, 2019 & 2028 (In %)
Figure 26: United States Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 27: Canada Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 28: Europe Opioids Drugs Market, Regional Outlook, 2019 & 2028 (In %)
Figure 29: United Kingdom Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 30: Germany Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 31: France Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 32: Italy Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 33: Russia Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 34: Belgium Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 35: Poland Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 36: Rest Of Europe Opioids Drugs Market, 2019-2028 (In $ Million)
Figure 37: Asia Pacific Opioids Drugs Market, Regional Outlook, 2019 & 2028 (In %)
Figure 38: China Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 39: Japan Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 40: India Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 41: South Korea Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 42: Indonesia Opioid Drugs Market, 2020-2028 (In $ Million)
Figure 43: Thailand Opioid Drugs Market, 2020-2028 (In $ Million)
Figure 44: Vietnam Opioid Drugs Market, 2020-2028 (In $ Million)
Figure 45: Australia & New Zealand Opioid Drugs Market, 2020-2028 (In $ Million)
Figure 46: Rest Of World Opioids Drugs Market, Regional Outlook, 2019 & 2028 (In %)
Figure 47: Latin America Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 48: Middle East And Africa Opioids Drugs Market, 2020-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - OPIOIDS DRUGS
TABLE 2: FDA APPROVED OPIOIDS WITH ADF LABELLING
TABLE 3: NUMBER OF LAWSUITS CASES SETTLED BY OPIOIDS MANUFACTURING COMPANIES AND PHARMACIES, 2015–2027
TABLE 4: LIST OF ER/LA OPIOID BRANDED DRUGS, 2017
TABLE 5: LIST OF ER/LA OPIOID GENERIC DRUGS, 2017
TABLE 6: CDC GUIDELINES ON PRESCRIBING OPIOIDS
TABLE 7: PIPELINE ANALYSIS OF OPIOID DRUGS
TABLE 8: GLOBAL OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: GLOBAL BUPRENORPHINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: GLOBAL BUPRENORPHINE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: GLOBAL FENTANYL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: GLOBAL FENTANYL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 14: GLOBAL HYDROCODONE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: GLOBAL HYDROCODONE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 16: GLOBAL MORPHINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: GLOBAL MORPHINE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 18: GLOBAL OXYCODONE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: GLOBAL OXYCODONE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 20: GLOBAL TRAMADOL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: GLOBAL TRAMADOL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 22: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 24: GLOBAL OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: GLOBAL OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 26: GLOBAL PAIN RELIEF MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: GLOBAL PAIN RELIEF MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 28: GLOBAL PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: GLOBAL PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 30: GLOBAL CANCER PAIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: GLOBAL CANCER PAIN MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 32: GLOBAL POSTOPERATIVE PAIN MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: GLOBAL POSTOPERATIVE PAIN MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 34: GLOBAL LOW BACK PAIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: GLOBAL LOW BACK PAIN MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 36: GLOBAL ORTHOPEDIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 37: GLOBAL ORTHOPEDIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 38: GLOBAL FIBROMYALGIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 39: GLOBAL FIBROMYALGIA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 40: GLOBAL NEUROPATHIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 41: GLOBAL NEUROPATHIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 42: GLOBAL ANESTHESIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 43: GLOBAL ANESTHESIA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 44: GLOBAL COUGH SUPPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 45: GLOBAL COUGH SUPPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 46: GLOBAL DIARRHEA SUPPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 47: GLOBAL DIARRHEA SUPPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 48: GLOBAL DEADDICTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 49: GLOBAL DEADDICTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 50: GLOBAL OPIOIDS DRUGS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 51: GLOBAL OPIOIDS DRUGS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 52: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 53: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 54: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 55: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 56: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 57: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 58: REST OF WORLD OPIOIDS DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 59: REST OF WORLD OPIOIDS DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)